DELCATH SYSTEMS, INC.

DCTH ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2017 FY2016 FY2015
Revenue $85.2M $37.2M $2.1M $2.7M $3.6M $2.7M $2.0M $1.7M
Cost of Revenue $11.8M $6.2M $635.0K $686.0K $671.0K $701.0K $550.0K $462.0K
Gross Profit $73.4M $31.0M $1.4M $2.0M $2.9M $2.0M $1.4M $1.3M
Gross Margin 86.2% 83.4% 69.2% 74.8% 81.1% 74.2% 72.4% 73.6%
Operating Expenses
Research & Development $29.2M $13.9M $17.5M $18.6M $13.8M $10.5M $8.4M $6.5M
SG&A Expense $43.5M $29.6M $22.1M $17.3M $13.6M $9.7M $9.4M $10.0M
Operating Income $660.0K $-12.4M $-38.2M $-33.9M $-24.5M $-18.2M $-16.4M $-15.2M
Operating Margin 0.8% -33.4% -1,849.0% -1,245.1% -690.0% -669.1% -825.3% -870.6%
Interest Expense $21.7M $14.3M $67.0K
Pretax Income $3.5M $-26.4M $-47.7M $-36.5M $-25.6M $-45.1M $-18.0M $-14.7M
Income Tax Expense $810.0K $0 $0 $0 $0 $0 $0 $0
Net Income $2.7M $-26.4M $-47.7M $-36.5M $-25.6M $-45.1M $-18.0M $-14.7M
Net Margin 3.2% -70.9% -2,308.9% -1,342.7% -721.5% -1,661.8% -902.2% -841.7%
EPS (Basic) $0.08 $-0.93 $-2.94 $-4.12 $-3.59 $-0.01 $-0.01 $0.00
EPS (Diluted) $0.07 $-0.93 $-2.94 $-4.12 $-3.59 $-0.01 $-0.01 $0.00
Shares Outstanding (Basic) 35.8M 28.5M 16.2M 8.9M 7.1M 5.98B 1.75T 6.89T
Shares Outstanding (Diluted) 39.9M 28.5M 16.2M 8.9M 7.1M 5.98B 1.75T 6.89T
Dividends Per Share
← Newer Page 1 of 2 Older →